These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33301729)

  • 1. Fungal infections should be part of the core outcome set for COVID-19 - Authors' reply.
    Marshall JC; Murthy S; Diaz J;
    Lancet Infect Dis; 2021 Jun; 21(6):e146. PubMed ID: 33301729
    [No Abstract]   [Full Text] [Related]  

  • 2. Fungal infections should be part of the core outcome set for COVID-19.
    Verweij PE; Alanio A
    Lancet Infect Dis; 2021 Jun; 21(6):e145. PubMed ID: 33301728
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing secondary fungal infections in severe COVID-19: how to move forward?
    Verweij PE; van de Veerdonk FL
    Lancet Respir Med; 2022 Feb; 10(2):127-128. PubMed ID: 34843664
    [No Abstract]   [Full Text] [Related]  

  • 4. Fungal infections in the era of COVID-19: Time to awaken to the Titanic.
    Singla N; Bansal Y
    Indian J Pathol Microbiol; 2024 Apr; 67(2):481-482. PubMed ID: 38391325
    [No Abstract]   [Full Text] [Related]  

  • 5. Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review.
    Samaranayake LP; Fakhruddin KS; Ngo HC; Bandara HMNM; Leung YY
    Int Dent J; 2022 Oct; 72(5):607-620. PubMed ID: 35367044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and Fungal infections: a double debacle.
    Mina S; Yaakoub H; Annweiler C; Dubée V; Papon N
    Microbes Infect; 2022; 24(8):105039. PubMed ID: 36030024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic mycoses: a potential alert for complications in COVID-19 patients.
    Segrelles-Calvo G; de S Araújo GR; Frases S
    Future Microbiol; 2020 Sep; 15():1405-1413. PubMed ID: 33085538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of SARS-CoV-2 in different environmental conditions - Authors' reply.
    Chin AWH; Poon LLM
    Lancet Microbe; 2020 Aug; 1(4):e146. PubMed ID: 33521712
    [No Abstract]   [Full Text] [Related]  

  • 9. Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Authors' Reply.
    Dhochak N; Lodha R
    Indian J Pediatr; 2022 Aug; 89(8):842. PubMed ID: 35499799
    [No Abstract]   [Full Text] [Related]  

  • 10. Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
    Oliu-Barton M; Pradelski BSR; Aghion P; Artus P; Kickbusch I; Lazarus JV; Vanderslott S
    Lancet; 2021 Oct; 398(10311):1566-1567. PubMed ID: 34755623
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study.
    Shafiekhani M; Shekari Z; Boorboor A; Zare Z; Arabsheybani S; Azadeh N
    Virol J; 2022 Mar; 19(1):35. PubMed ID: 35246169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 rapid antigen detection tests - Authors' reply.
    Peeling RW; Olliaro P; Boeras D; Fongwen N
    Lancet Infect Dis; 2021 Aug; 21(8):1069-1070. PubMed ID: 33961801
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 and electrocardiography: is electrocardiography a predictor of mortality?-Authors' reply.
    Lanza GA; De Vita A
    Europace; 2021 Jul; 23(7):1151. PubMed ID: 34077534
    [No Abstract]   [Full Text] [Related]  

  • 14. Transmissibility of SARS-CoV-2 among fully vaccinated individuals - Authors' reply.
    Lalvani A; Hakki S; Singanayagam A; Dunning J; Barnett JL; Crone MA; Freemont PS; Ferguson NM
    Lancet Infect Dis; 2022 Jan; 22(1):18-19. PubMed ID: 34953543
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucormycosis: time to address this deadly fungal infection.
    Stone N; Gupta N; Schwartz I
    Lancet Microbe; 2021 Aug; 2(8):e343-e344. PubMed ID: 35544192
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19-associated rhino-orbital- cerebral mixed mycoses with intracranial fungal granuloma - An aggressively managed rare entity.
    Sahu ES; Sahu A; Ghodgaonkar P; Lahoti K; Bhargava A
    Indian J Ophthalmol; 2021 Sep; 69(9):2537-2539. PubMed ID: 34427263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invisible spread of SARS-CoV-2 - Authors' reply.
    Kucharski AJ; Eggo RM
    Lancet Infect Dis; 2020 Sep; 20(9):1012. PubMed ID: 32275870
    [No Abstract]   [Full Text] [Related]  

  • 18. Opportunistic mycoses in COVID-19 patients/survivors: Epidemic inside a pandemic.
    Kuchi Bhotla H; Balasubramanian B; Meyyazhagan A; Pushparaj K; Easwaran M; Pappusamy M; Alwin Robert A; Arumugam VA; Tsibizova V; Msaad Alfalih A; Aljowaie RM; Saravanan M; Di Renzo GC
    J Infect Public Health; 2021 Nov; 14(11):1720-1726. PubMed ID: 34700291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? - Authors' reply.
    Tsang NNY; So HC; Ip DKM
    Lancet Infect Dis; 2021 Oct; 21(10):1348-1349. PubMed ID: 34363770
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.